First Commonwealth Financial Corp PA Reduces Position in Humana Inc. (NYSE:HUM)

First Commonwealth Financial Corp PA lowered its holdings in Humana Inc. (NYSE:HUM) by 4.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,959 shares of the insurance provider’s stock after selling 94 shares during the period. First Commonwealth Financial Corp PA’s holdings in Humana were worth $620,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in HUM. Mendota Financial Group LLC increased its holdings in Humana by 9.2% in the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock valued at $119,000 after buying an additional 27 shares during the period. Capital Advisors Ltd. LLC grew its holdings in shares of Humana by 17.0% during the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after purchasing an additional 31 shares during the last quarter. CarsonAllaria Wealth Management Ltd. increased its position in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares in the last quarter. Moors & Cabot Inc. lifted its holdings in Humana by 2.5% during the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after buying an additional 40 shares in the last quarter. Finally, Harbour Investments Inc. boosted its holdings in Humana by 10.5% in the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after acquiring an additional 41 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HUM has been the topic of a number of analyst reports. Wells Fargo & Company cut their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Cantor Fitzgerald restated a “neutral” rating and set a $395.00 price objective on shares of Humana in a research note on Tuesday, October 1st. UBS Group dropped their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Stephens restated an “equal weight” rating and set a $250.00 target price on shares of Humana in a research note on Wednesday, October 9th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Twenty investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $315.86.

Humana Stock Up 0.4 %

HUM stock traded up $1.20 during midday trading on Wednesday, reaching $296.79. 33,127 shares of the company’s stock traded hands, compared to its average volume of 1,864,426. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm’s fifty day moving average price is $276.28 and its 200-day moving average price is $330.23. The company has a market cap of $35.74 billion, a price-to-earnings ratio of 26.17, a P/E/G ratio of 2.40 and a beta of 0.52. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $526.47.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. As a group, sell-side analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.